Skip to main navigation
About us
Our Approach
Our Pipeline
Patients
Investors
Careers
About us
Our Approach
Our Pipeline
Patients
Investors
Careers
Overview
Corporate Presentation
Overview
News & Events
News Releases
Events
Stock Information
Stock Quote & Chart
Analyst Coverage
Corporate Governance
Governance Overview
Board of Directors
Leadership
Financial Information
SEC Filings
SEC Filings - AGLE
Quarterly Results
IR Resources
Investor FAQs
Email Alerts
Contact IR

SEC Filing Details

Document Details

Form
SCHEDULE 13D/A
Filing Date
Jun 23, 2026
Document Date
Jun 23, 2026
Form Description
SCHEDULE 13D/A - Description
Filing Group
Other
Company
Spyre Therapeutics
Issuer
SPYRE THERAPEUTICS, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
  • Our Approach
  • Approach
  • Therapeutic Targets
  • Half-life Extension
  • Rational Combinations
  • Publications
  • Our Programs
  • Pipeline
  • Programs
  • Investors
  • Corporate Presentation
  • Overview
  • News & Events
  • Stock Information
  • Financial Information
  • Corporate Governance
  • IR Resources
  • Patients
  • Spyre Commitment
  • Clinical Trials & Disease Ed
  • Careers
  • Values
  • Benefits
  • Careers
  • About Us
  • People
  • Contact
Subscribe
to stay updated
  • Terms of Service
  • Privacy Policy
© 2026 Spyre Therapeutics. All rights reserved. For U.S. residents only.
Design and development by Visual Science